Yale researchers have developed a machine learning model, called Immunostruct, that can help scientists create more ...
In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC; Real‑world evidence showed Pluvicto achieved longer PFS when init ...
Artificial intelligence is transforming medicine, but what does that mean for breast cancer screening? Researchers at UMass Chan Medical School are exploring how an AI-based tool might help identify ...
A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.
Discover how AI is transforming nutritional science by turning complex diet and omics data into predictive tools that reshape chronic disease prevention and personalized care.
The interplay between host immunity, the microbiota, and cancer is a rapidly evolving area of immuno-oncology. An increasing body of evidence highlights the ...